Adventris makes cancer vaccines
Adventris Pharmaceuticals has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in April 2023.
Adventris Pharmaceuticals's investors include Y Combinator.
Adventris Pharmaceuticals is headquartered in San Francisco, United States.
Adventris makes cancer vaccines
Adventris Pharmaceuticals is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Adventris Pharmaceuticals — Funding & Investors." VCBacked, April 5, 2023, https://www.vcbacked.co/company/adventris-pharmaceuticals. Accessed August 1, 2026.
VCBacked. (2023). Adventris Pharmaceuticals — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/adventris-pharmaceuticals
{{cite web |title=Adventris Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/adventris-pharmaceuticals |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated